Rivaroxaban
NDC 60505-6256, Rivaroxaban, tablet, film coated, from Apotex Corp..
- Product NDC
- 60505-6256
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217810
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6256 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVAROXABAN2.5 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6256-5 | 60505625605 | 500 TABLET, FILM COATED in 1 BOTTLE (60505-6256-5) |
| 60505-6256-6 | 60505625606 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-6256-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e98f6d83-5172-97a1-ee41-5d7d1d8ba2fdNADAC price for package 60505625606
GET /v1/drugs/nadac/60505625606
Use it
Look up 60505-6256 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6256 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6256. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.